Story details

   Live Viewers: 2100      Total Pageviews: 4930

A Year After Approval, Gene-Therapy Cure Gets Its First Customer

GlaxoSmithKline says it has treated a child with Strimvelis, its gene therapy for immune deficiency.

Attached file(s)

Submit a Comment (Logged In Users)

Log in to comment or register here

Don't Miss the Next Big Thing.

Stay Updated with Awesome Science Stuffs.